3-Day Conference: Liquid Biopsies 2019 (San Diego, CA, United States - March 27-29, 2019) - ResearchAndMarkets.com

February 12, 2019

DUBLIN--(BUSINESS WIRE)--Feb 12, 2019--The “Liquid Biopsies 2019” conference has been added to ResearchAndMarkets.com’s offering.

Liquid Biopsies 2019 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.

There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring, and minimal residual disease detection.

This conference is held concurrently with the Circulating Biomarkers 2019 Conference enabling delegates full access to the scientific presentations at both conferences, co-located exhibit hall, and extensive networking opportunities.



08:00 - Conference Registration, Materials Pick-Up, Morning Coffee and Breakfast Pastries

08:45 - Conference Chair

09:00 - Keynote Presentation

09:30 - Keynote Presentation

10:00 - Coffee Break and Networking in the Exhibit Hall

10:45 - Keynote Presentation

11:15 - Conference Chair

11:45 - Keynote Presentation

12:15 - Networking Lunch in the Exhibit Hall and Poster Viewing

14:00 - Ultrasensitive Detection of Cancer Using cfDNA Methylation Sequencing

14:30 - Low Coverage, Genome-Wide Sequencing of Cell-Free DNA Enables the Monitoring of Response to Immunotherapy in Cancer Patients

15:00 - Ultra-Sensitive Mutational Analysis in Cell-Free DNA by Digital PCR and NGS Technologies

15:30 - Afternoon Coffee Break in the Exhibit Hall

16:00 - Early Cancer Detection in Plasma by Methylation Haplotyping

16:30 - Monitoring Recurrence With Personalized ctDNA Assays

17:00 - cfDNA Analysis in ALK-positive NSCLC Patients and Potential Clinical Utility

18:00 - Networking Reception with Beer and Wine in the Exhibit Hall

19:00 - Close of Day 1 of the Conference


08:30 - Morning Coffee and Breakfast Pastries Served in the Exhibit Hall

09:00 - Keynote Presentation

09:30 - Circulating Tumor DNA Analyses in Lung Cancer

10:00 - Keynote Presentation

11:00 - Circulating Biomarkers: The New Nanotube-CTC-Microarray Chip for Clinical Impact

11:30 - Keynote Presentation

12:00 - Networking Lunch in the Exhibit Hall and Poster Viewing

13:00 - Quantitative Detection of Gene Rearrangements Using Circulating Tumor Cells Purified by a Covalent Chemistry-Enabled Platform

13:30 - Keynote Presentation

14:00 - Keynote Presentation

14:30 - Title to be Confirmed

15:00 - Characterizing Cell-Free Circulating RNA - A Dream or a Reality?

15:30 - Afternoon Coffee Break in the Exhibit Hall

16:00 - Keynote Presentation

16:30 - Circulating Tumor DNA Methylation Markers for Diagnosis and Prognosis of Hepatocellular Carcinoma

17:30 - Industry Panel Discussion Focusing on Circulating Biomarkers & Liquid Biopsy

18:15 - Close of Day 2 of the Conference Track

DAY 3 - FRIDAY, 29 MARCH 2019

08:30 - Morning Coffee and Breakfast Pastries Served in the Exhibit Hall

09:00 - Highly Sensitive Direct Quantification of cfmiRNAs for Biomarker Profiling by Next Generation Sequencing (NGS)

09:30 - Applying ctDNA and Other Liquid Biopsy Technologies for Oncology Translational and Clinical Research

10:00 - BloodPAC: Establishing Standards to Accelerate Development and Approval of Liquid Biopsy Technology

10:30 - Toward Perfect Detection of Un-amplified Biomarkers with Single-Molecule Kinetic Fingerprinting

11:00 - Keynote Presentation

For more information about this conference visit https://www.researchandmarkets.com/research/38hk3x/3day_conference?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190212005375/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:In Vitro Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/12/2019 04:49 AM/DISC: 02/12/2019 04:49 AM


Update hourly